News

FDA cleared Masimo's pediatric Patient State Index, a SedLine EEG-based sedation score calibrated for children aged 4 and older.

In the OUTMATCH trial, omalizumab achieved higher treatment success than multiallergen oral immunotherapy, largely because of fewer adverse events.

CSL reported that most children receiving garadacimab remained attack-free in a recent phase 3b study of garadacimab-gxii for prevention of hereditary angioedema.

The FDA has approved novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) centanafadine for ADHD in children, adolescents, and adults

FDA approved Tylenol with Naproxen, the first OTC fixed-dose acetaminophen/naproxen sodium tablet, for 12-hour pain relief in patients 12 and older.

US measles cases have climbed to 2,318 in 2026, already exceeding all of 2025 and marking the country's highest annual total since 1991, as CDC data show falling MMR coverage continuing to fuel outbreaks.

A pooled ADORING trial analysis found tapinarof cream improved skin clearance by week 2 across ages 2 through adulthood in atopic dermatitis.

Serial prenatal amnioinfusions improved survival in fetal renal failure, but surviving infants require complex multidisciplinary care after birth.

Jon Farber, MD, shares his thoughts on the diagnosis of slipped capital femoral epiphysis.

Jon Farber, MD, shares his thoughts on the efficacy of laser therapy for temporal lobe epilepsy.

Olivia Kim-McManus, MD, discusses how personalized antisense therapy reduced seizures and improved development in 2 children with SCN2A-related developmental epileptic encephalopathy.

Jon Farber, MD, shares his thoughts on probiotics for reducing gastrointestinal (GI) problems in autism spectrum disorder (ASD).

Study finds higher intake of ultra-processed foods in early childhood linked to lower volume of several subcortical brain regions by age 6.

The PECOS study found 20 post-COVID symptoms in children; Roberta L. DeBiasi, MD, discusses evaluation and follow-up.

Joyce Woo, MD, says timely diagnosis, coordinated transfer, and early surgical planning may improve care for newborns with severe congenital heart defects.

A new AAP/NASPGHAN guideline replaces "failure to thrive" with "faltering weight" and adopts z-score-based diagnostic criteria in place of percentiles.

Study highlights prenatal diagnosis gaps and hospital-level factors that may affect timely transfer for newborns with severe congenital heart defects.

Alesia McKeown, PhD, of Roche Diagnostics discusses why pertussis is missed in children and adolescents and how PCR testing can help.

Udenafil lowered ELF scores after 12 months in an exploratory Fontan substudy, but liver stiffness measures did not significantly change.

Later transfer to a cardiac surgical center was associated with longer hospitalization for newborns with severe congenital heart defects, Joyce Woo, MD, MS, explains.

Pediatric guidance for Deaf and hard-of-hearing children highlights 1-3-6 screening benchmarks, early intervention, early ASL exposure, and timely hearing technology for stronger language outcomes.

With a multistate cyclosporiasis outbreak underway this summer, pediatric providers should maintain a low threshold to consider Cyclospora cayetanensis in children with protracted or relapsing watery diarrhea.

An adolescent medicine specialist says pediatricians should proactively discuss social media skincare trends to help prevent skin irritation and misinformation.

The FDA granted priority review to obinutuzumab for relapsing/steroid-dependent pediatric INS, based on phase 3 INShore remission data

An adolescent medicine expert says social media skincare routines may increase skin irritation and atopic dermatitis in teens.

A 2-million-infant Swedish registry study found intramuscular vitamin K nonreceipt rose over 19 years and nearly tripled the odds of intracranial bleeding by 6 months.

FDA accepted BioMarin's sNDA to convert vosoritide's achondroplasia indication to full approval, with a PDUFA date of February 28, 2027.

FDA sent a letter urging infant formula makers to strengthen supply chain oversight after 2 US botulism outbreaks and a global cereulide contamination event.